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Abstract Age is the strongest independent risk factor for
the development of osteoarthritis (OA) and for many years
this was assumed to be due to repetitive microtrauma of the
joint surface over time, the so-called ‘wear and tear’
arthritis. As our understanding of OA pathogenesis has
become more refined, it has changed our appreciation of
the role of ageing on disease. Cartilage breakdown in
disease is not a passive process but one involving induction
and activation of specific matrix-degrading enzymes;
chondrocytes are exquisitely sensitive to changes in the
mechanical, inflammatory and metabolic environment of
the joint; cartilage is continuously adapting to these
changes by altering its matrix. Ageing influences all of
these processes. In this review, we will discuss how ageing
affects tissue structure, joint use and the cellular metabo-
lism. We describe what is known about pathways impli-
cated in ageing in other model systems and discuss the
potential value of targeting these pathways in OA.
Osteoarthritis (OA) is the most common form of arthritis
worldwide and constitutes a huge societal burden (Woolf
and Pfleger 2003; Glyn-Jones et al. 2015). This will likely
increase as lifespan in the global population rises (Woolf
and Pfleger 2003; Glyn-Jones et al. 2015). OA is a highly
heterogeneous disease that affects all synovial joints,
including the hand, knee, hip and spine and is characterised
by the progressive degradation of the articular cartilage
along with secondary bone remodelling and episodic syn-
ovitis (Vincent and Watt 2014). Ageing is the most
important aetiological risk factor. Other important factors
include obesity, genetics and, in younger individuals, acute
destabilising joint injuries (Bijlsma et al. 2011). Several
mechanisms have been proposed by which ageing impacts
on the progression of joint degeneration in OA. This review
will highlight and discuss the cellular metabolic mecha-
nisms that are dysregulated in ageing cartilage and which
may contribute to disease pathogenesis.
Pathogenesis of OA
Breakdown of the articular cartilage with remodelling of
the underlying bone is the hallmark of OA. The articular
cartilage is an exquisitely lubricated tissue located on the
surface of the joint, responsible for smooth joint articula-
tion (Pearle et al. 2005). Cartilage is avascular and aneural
and contains just one cell type, the chondrocyte. 95 % of
the cartilage volume is extracellular matrix, composed of
predominantly type II collagen and the proteoglycan,
aggrecan (Pearle et al. 2005). Chondrocytes are responsible
for maintaining homeostatic cartilage turnover to renew
and respond to changes in the mechanical environment, but
excessive matrix catabolism can be driven by excessive
mechanical joint loading, cytokines, growth factors and
fragments of the extracellular matrix (ECM) (Wieland
et al. 2005). Principle matrix-degrading enzymes include
members of the ‘a disintegrin and metalloproteinase with
thrombospondin motif’ (ADAMTS) family (largely
ADAMTS5) and the matrix metalloproteinase (MMP)
family (largely MMP1, 8 and 13), which degrade aggrecan
and collagen, respectively (Nagase et al. 2006). The sig-
nificance of these enzymes in vivo was demonstrated by
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showing that mice deficient in either ADAMTS5 or
MMP13 had reduced cartilage degradation scores follow-
ing surgically induced murine OA (Glasson et al. 2005;
Little and Smith 2008). Interleukin 1-beta (IL-1b) and
tumour necrosis factor-alpha (TNFa) are capable of
inducing and activating these catabolic enzymes to degrade
cartilage (Saklatvala 1981, 1986). However, there is scant
evidence that these cytokines are central in driving disease
in vivo (Clements et al. 2003; Glasson 2007; Fukai et al.
2012).These enzymes can be induced rapidly upon surgical
joint destabilisation in a highly mechano-sensitive manner
as well; gene regulation and disease is abrogated if the joint
is immobilised following surgery. This suggests that
mechanical factors can also initiate pathogenic pathways
(Burleigh et al. 2012). This accords well with epidemio-
logical evidence that OA may principally be driven by
mechanical joint overload and injury (Brandt et al. 2009;
Nagase et al. 2006; Nagase and Kashiwagi 2003).
The significance of joint inflammation in contributing to
tissue breakdown is unclear. Infiltration of mononuclear
cells into the synovial membrane is observed in human OA
(Scanzello and Goldring 2012) and there is much evidence
to support activation of the innate immune system in dis-
ease (Orlowsky and Kraus 2015). It seems likely that
inflammation, when present, will exacerbate tissue break-
down and contribute to painful episodes of disease.
Age and osteoarthritis
The mechanisms by which age affects cartilage health are
multiple and varied but probably not simply due to accu-
mulated ‘wear and tear’ over time (Fig. 1). It is well
established that type II collagen has negligible turnover
during the normal adult lifetime but becomes biochemically
modified (crosslinked) with age (Bank et al. 1998). Carti-
lage proteoglycan, whilst having a much shorter half-life, is
also modified with age (Hickery et al. 2003; Lauder et al.
2001). Collectively, this significantly changes the stiffness
of the matrix (Bank et al. 1998) and likely affects not only
its ‘brittleness’, making it more susceptible to fracture, but
also its ability to sense and respond to mechanical load.
Indeed, the impaired ability of aged cartilage to activate
transforming growth factor beta 1 (TGFb1)-dependent sig-
nals upon mechanical compression may be related to this
(Madej et al. 2015). Interestingly, Loeser et al. (2013) used
a surgical OA model in 12-week-old and 12-month-old
male mice. Not only did the older mice exhibit increased
OA disease scores, but gene expression profiles were also
significantly different in the aged mice (Loeser et al. 2013).
Mechano-protective mechanisms are also substantially
diminished in ageing. Such mechanisms include protection
afforded by muscle ‘splinting’ of the joint upon weight-
bearing activity. Muscle atrophy is highly prevalent in
elderly populations (Brook et al. 2016) and very likely
contributes to loss of joint protection during the normal gait
cycle with age. This is amplified by loss of gait reflexes
whereby deceleration of movement upon heel strike would
normally occur in a younger individual but is lost in the
elderly (reviewed in Brandt et al. 2009).
One significant advance over the past decade or so has
been the characterisation of the cellular metabolic pathways
that are affected by ageing (Fig. 2). Largely, these pathways
have been defined in other model systems and in recent years
studied in the joint. Despite global recognition that OA is a
whole joint disease, most studies to date have focused on
Fig. 1 OA pathogenesis.
Proteolytic matrix breakdown is
a key feature of cartilage
breakdown in OA. This is
influenced by risk factors such
as age, inflammation and
mechanical injury. The ability
of cartilage to repair is
controversial but is also likely to
be influenced by similar classes
of modulators that may hinder
or aid repair
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cartilage when studying ageing mechanisms in OA. The rest
of this review will focus on how ageing pathways are
affected in joint cells and the likely significance of these
pathway changes on cartilage degradation in OA.
Autophagy
Autophagy is a cellular homeostatic mechanism for the
removal of dysfunctional organelles and proteins (Boya
et al. 2013). Defective autophagy is a key feature of age-
related diseases and recent observations indicate that this
process is compromised in ageing cartilage (Rubinsztein
et al. 2011; Lotz and Carame´s 2011). Carame´s et al. (2010)
examined key autophagy proteins in human and murine
cartilage. These markers were Unc-51-like kinase 1
(ULK1), an inducer of autophagy, Beclin1, a regulator of
autophagy, and microtubule-associated protein 1 light
chain 3 (LC3), which executes autophagy (Lotz and Car-
ame´s 2011). The expression of ULK1, Beclin1 and LC3
protein was reduced in human OA chondrocytes and car-
tilage (Carame´s et al. 2010). In mouse knee joints,
decreased protein expression of ULK1, Beclin1 and LC3
was associated with proteoglycan loss and increased
apoptosis at 9 and 12 months of age and following
induction of OA by joint destabilisation (Carame´s et al.
2010). A further study by Carame´s et al. (2015) showed
that 28-month-old mice had significant reduction in the
total number of autophagocytic vesicles per cell in articular
cartilage compared with young 6-month-old mice. Inter-
estingly, Bouderlique et al. (2015) generated a cartilage-
specific inducible ATG5 KO (ATG5cKO) mouse which
developed severe OA with increased cell death when aged.
Surprisingly, no difference in the development of post-
traumatic OA was observed between ATG5cKO and con-
trol mice post DMM (Bouderlique et al. 2015).
Studies have also examined the role of mammalian
target of rapamycin (mTOR) signalling which when acti-
vated inhibits ULK1 and in turn inhibits autophagy. Zhang
et al. (2014) reported upregulation of mTOR expression
that correlated with increased chondrocyte apoptosis and
reduced expression of key autophagy genes in human OA
tissue. In addition, inducible cartilage-specific mTOR KO
mice displayed increased autophagy signalling and signif-
icant protection from surgically induced OA associated
with a significant reduction in the apoptosis (Zhang et al.
2014). Carames et al. (2012) used rapamycin to pharma-
cologically inhibit mTOR in mice. The severity of cartilage
degradation was significantly reduced in the rapamycin-
treated group compared with the control group and this was
associated with a significant decrease in synovitis 10 weeks
post-surgery (Carames et al. 2012). Rapamycin treatment
also maintained cartilage cellularity and decreased
ADAMTS5 and IL-1b expression in articular cartilage
(Carames et al. 2012).
Sirtuins
The well-conserved Sirtuin gene family has been strongly
associated with longevity since silent information regulator
2 was shown to extend lifespan in budding yeast, worms,
flies and mice (Giblin et al. 2014). In mammals, Sirtuins
are a seven-member family (SirT1-7) of NAD-dependent
deacetylases, with SirT4 and SirT6 also demonstrating
ADP-ribosyltransferase activity (Verdin 2014). The Sirtu-
ins are involved in a wide range of physiological systems
and cellular functions including cell metabolism, apoptosis,
growth, development, inflammation and stress responses
(Sacitharan et al. 2012; Morris 2013). To date, only SirT1
and SirT6 have been investigated in OA.
Fig. 2 Cellular ageing
mechanisms. Many cellular
signalling mechanisms have
been implicated in the
regulation of ageing in
mammals. This review will
discuss the metabolic cellular
mechanisms (in bold) described
to be important in chondrocytes,
cartilage and the OA joint
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Mice with SirT6 haploinsufficiency fed on high-fat diet
had increased OA scores at 6 months of age compared with
wild-type animals fed on a similar diet (Ailixiding et al.
2015). No change in OA score was reported between mice
with SirT6 haploinsufficiency and control mice fed on a
normal diet (Ailixiding et al. 2015). Wu et al. (2015)
reported significantly decreased SirT6 protein expression
levels in articular chondrocytes of OA patients compared
with normal human chondrocytes. In addition, intraarticu-
lar injection of lentiviral-driven SirT6 in mice reduced OA
disease scores 8 weeks post-surgical destabilisation com-
pared with mice receiving the lentiviral vector control (Wu
et al. 2015).
Most Sirtuin-focussed OA research to date has been
around SirT1. SirT1 expression is decreased in human
articular chondrocytes in response to nutritional, catabolic
or mechanical stress (Takayama et al. 2009). Dvir-Ginz-
berg et al. (2008) showed that overexpression of SirT1 in
chondrocytes isolated from articular cartilage of human
joints resulted in an increase in cartilage-specific gene
expression of collagen 2(a1) (COL2A1) through the
deacetylation of SOX-9 (Dvir-Ginzberg et al. 2008). Sim-
ilarly, decreased expression of aggrecan, COL2A1 and
collagen 9(a1) was observed in SirT1 siRNA-treated
human knee chondrocytes (Fujita et al. 2011). Conversely,
decreasing SirT1 resulted in the upregulation of collagen
10(a1) and ADAMTS5 gene expression (Fujita et al.
2011).
Gabay et al. (2012) demonstrated that SirT1 constitu-
tive whole-body knockout mice had increased OA disease
scores and exhibited low levels of COL2A1, ACAN,
GAG release and high protein levels of MMP-13. These
studies were performed at 3 weeks of age as constitutive
SirT1 KO mice only survive for a few weeks post-partum.
The same group generated mice in which a point mutation
renders SirT1 inactive, had increased levels of apoptotic
chondrocytes and increased OA disease scores when
compared with age-matched (9 months) wild-type control
mice (Gabay et al. 2013). Matsuzaki et al. (2013) gen-
erated cartilage-specific SirT1 conditional knockout
(Sirt1-cKO) mice using an inducible collagen II-driven
Cre recombinase (COL2A1-ERT2 Cre). Sirt1-cKO mice
showed accelerated OA progression at 2 and 4 (but not
surprisingly 8) weeks post joint destabilisation. In addi-
tion, spontaneous OA scores were significantly higher in
1-year-old Sirt1-cKO mice than in control mice (Mat-
suzaki et al. 2013). Together, these studies to date suggest
that SirT1 may have a protective role in cartilage. The
specific targets of SirT1 and precise mechanisms of action
are as yet unclear.
IGF1
The evolutionarily conserved insulin/IGF1 signalling (IIS)
pathway plays a key role in hormonal regulation during
ageing (van Heemst 2010). IGF1 has potent anabolic
effects on cells and downstream activation of cell prolif-
eration, modulation of tissue differentiation and protection
from apoptosis (van Heemst 2010). Mice with mutations in
the IGF1 receptor display altered longevity. Female but not
male mice with a heterozygous IGF1R mutation lived
longer and demonstrated increased resistance to oxidative
stress (Holzenberger et al. 2003). In addition, Klotho, a
transmembrane protein which when overexpressed inhibits
IGF1 signalling in mice extends lifespan (Kurosu et al.
2005). Klotho mutant mice age prematurely (Kuro-o 2009).
The role of IGF1 in articular cartilage metabolism has
been extensively investigated as well. Interestingly, IGF1
was identified by Salmon and Daughaday (1957) and
originally named as ‘‘sulphation factor’’ because of its
ability to stimulate 35-sulphate incorporation into rat car-
tilage. Exogenous IGF1 when added to monolayers of
bovine chondrocytes or cartilage explants increases pro-
teoglycan synthesis (Sah et al. 1994). Furthermore, a
combination of IGF1 and TGFb1 has been shown to reg-
ulate proliferation and differentiation of periosteal mes-
enchymal cells during chondrogenesis (Fukumoto et al.
2003). However, addition of IGF1 alone did not have the
same effect on chondrogenesis (Fukumoto et al. 2003).
This result validates the experiments conducted by Tsu-
kazaki et al. (1994) who showed the ability of TGFb1 to
increase the number of IGF1 receptors in chondrocytes
without changing their affinity. IGF1-deficient rats devel-
oped articular cartilage lesions (Ekenstedt et al. 2006) and
in murine and equine models addition of IGF1 to chon-
drocyte grafts enhanced chondrogenesis in cartilage defects
(Fortier et al. 2002; Goodrich et al. 2007). These studies
further support the need for IGF1 to maintain articular
cartilage integrity. Several studies have demonstrated that
the ability of chondrocytes to respond to IGF1 decreases
with age and in OA (Loeser et al. 2000; Morales 2008).
Oxidative stress
Reactive oxygen species (ROS) are produced as a result of
cellular metabolism and environmental factors (Nathan and
Cunningham-Bussel 2013). ROS can damage nucleic acids
and proteins, thus altering their functions (Gorrini et al.
2013). Hence, cells produce antioxidants to counteract
oxidative stress caused by ROS (Gorrini et al. 2013;
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Nathan and Cunningham-Bussel 2013). Accumulation of
nitrotyrosine, a marker of protein oxidation, is seen in
ageing normal human and monkey cartilage and OA
human cartilage (Loeser et al. 2002). Oxidative stress with
ageing has been shown to make human chondrocytes more
susceptible to apoptosis through the dysregulation of the
glutathione antioxidant system (Carlo and Loeser 2003).
Reduced levels of catalase were observed in aged rat
chondrocytes (15–18 months) compared with chondrocytes
from young adult rats (6 months old) (Jallali et al. 2005).
Furthermore, reductions in mitochondrial superoxide dis-
mutase, manganese-superoxide dismutase and glutathione
peroxidase were all observed in isolated chondrocytes from
OA tissue samples (Aigner et al. 2006; Ruiz-Romero et al.
2006, 2009). ROS are also produced by chondrocytes in
response to stimulation by cytokines and growth factors,
including IL-1, TNFa and TGFb1 (Lo and Cruz 1995;
Jallali et al. 2007; Loeser 2012). Baker et al. (1988)
demonstrated that hydrogen peroxide (H2O2) suppressed
proteoglycan synthesis in human cartilage explant culture.
This could be potentiated when catalase and the glutathione
peroxidase/reductase systems were inhibited (Baker et al.
1988). The role of oxidative stress mediators in cartilage
health is unknown although it is interesting that H2O2 is an
important tissue injury signal in other model systems and
drives repair responses (Razzell et al. 2013).
ER stress and UPR
The ER is arranged in a dynamic tubular network and
protein maturation at the ER is vital for the correct folding
of proteins (Hetz 2012). Several feedback mechanisms are
in place to cope with impaired protein folding which causes
ER stress and may lead to apoptosis (Hetz 2012). These
coping mechanisms together are known as the unfolded
protein response (UPR) (Ron and Walter 2007). The UPR
signalling network is complex and requires several key
components (Ron and Walter 2007). UPR stress sensors,
inositol-requiring protein 1a (IRE1a), protein kinase RNA-
like endoplasmic reticulum kinase (PERK) and activating
transcription factor 6 (ATF6), signal information about the
folding status of the ER proteins to the cytosol and nucleus
to suppress new protein synthesis and restore optimal
protein-folding capacity (Ron and Walter 2007; Hetz
2012). The transcription factors mentioned above activate
UPR target genes involved in pathways such as autophagy,
apoptosis, lipid synthesis and NF-jB signalling thereby
minimising the effects of ER stress (Ron and Walter 2007;
Hetz 2012).
In vitro studies have shown increased UPR in OA
articular chondrocytes predominately through the PERK
and IRE1 pathways (Liu-Bryan and Terkeltaub 2015). In
addition, Husa et al. (2013) showed that biomechanical
injury, IL-1b and nitric oxide (NO) increase ER stress and
the UPR in cultured bovine chondrocytes. Interestingly,
transfection of CHOP in ‘gain of function’ experiments
sensitised normal human chondrocytes to IL-1b-induced
NO and MMP3 release without inducing these responses
by itself (Husa et al. 2013). It must be noted that excessive
CHOP signalling induces ER stress as well, by increasing
protein synthesis (Ron and Walter 2007; Hetz 2012).
Hence CHOP signalling needs to be finely regulated. Sur-
gically induced OA in mice in which CHOP was consti-
tutively deleted were partially protected from increased
chondrocyte apoptosis and cartilage degradation (Uehara
et al. 2014), although there was no difference in ER stress
between CHOP KO mice and control mice (Uehara et al.
2014).
XBP1, a UPR transcription factor, has a role in chon-
drocyte differentiation. Overexpression of XBP1 in chon-
drocyte cell lines led to accelerated chondrocyte
hypertrophy as shown by increased expression of type X
collagen and Runt-related transcription factor 2 (RUNX2)
(Liu et al. 2012). Conversely, knockdown of XBP1 by
siRNA abolished hypertrophic chondrocyte differentiation
(Liu et al. 2012). Takada et al. (2011) showed enhanced
apoptosis in XBP1-induced ATF6 signalling in osteoar-
thritic cartilage. As several new compounds for alleviating
ER stress are being developed and tested in other disease
areas (Hetz 2012), it is likely that studies will soon follow
in OA models.
AMPK
The serine/threonine kinase AMP-activated protein kinase
(AMPK) is a master regulator of cellular energy and
adjusts to changes in energy demand (Salminen and
Kaarniranta 2012). Terkeltaub et al. (2011) first described
normal human knee articular chondrocytes which expres-
sed AMPKa1, a2, b1, b2 and c1 subunits with constitutive
and robust activity. However, AMPK activity was
decreased in OA articular chondrocytes and cartilage and
in normal chondrocytes treated with IL-1b and TNFa
(Terkeltaub et al. 2011). Knockdown of AMPKa resulted
in enhanced catabolic responses to IL-1b and TNFa in
chondrocytes (Terkeltaub et al. 2011). AMPK activators
(AICAR and A-769662) suppressed pro-catabolic respon-
ses to IL-1b and TNFa from chondrocytes (Terkeltaub
et al. 2011). A further study by the same group revealed
that AMPK activity was decreased in mouse knees post-
surgical destabilisation and in aged knee cartilage
(6–24 months), as well as in bovine chondrocytes after
biomechanical injury (Petursson et al. 2013). This study
further identified an upstream kinase, the liver protein
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kinase B1 (LKB1) as the promoter of AMPK activity in
chondrocytes (Petursson et al. 2013). Knockdown of LKB1
attenuated chondrocyte AMPK activity and increased NO,
MMP3 and MMP13 release in response to IL-1b and TNFa
(Petursson et al. 2013). LKB1, like AMPK, also decreased
in diseased and aged murine knee cartilage (Petursson et al.
2013). In addition, pre-treatment of bovine chondrocytes
with AMPK activators inhibited the catabolic response of
NO after biomechanical injury (Petursson et al. 2013).
Other transcriptional regulators
FOXO transcription factors are involved in the regulation of
the cell cycle, apoptosis, metabolism and autophagy (Eijke-
lenboom and Burgering 2013). Multiple and diverse upstream
pathways regulate FOXO activity through post-translational
modifications and nuclear-cytoplasmic shuttling (Eijkelen-
boom and Burgering 2013). Healthy human cartilage (from
humans aged between 23 and 90) expresses FOXO1 and
FOXO3 but not FOXO4 protein subtypes (Akasaki et al.
2014a, b). During ageing, expression of FOXO1 and FOXO3
markedly decreases in the superficial zone of human cartilage
regions exposed to maximal weight bearing (Akasaki et al.
2014a, b). Similar patterns of FOXO expression have been
observed in mice upon ageing (4–24 months) and following
joint destabilisation (Akasaki et al. 2014a, b). FOXO1 protein
expression was suppressed in human chondrocytes when
cultured with IL-1b and TNFa, while TGFb increased
FOXO1 and FOXO3 protein expression (Akasaki et al. 2014a,
b). Akasaki et al. 2014a, b reported reduced expression of
FOXO transcription factors and increased cell death following
oxidative stress in chondrocytes.
Interestingly, this increase in cell death was accompa-
nied by reduced levels of antioxidant proteins (glutathione
peroxidase 1 and catalase) and autophagy-related proteins
(LC3 and Beclin1) (Akasaki et al. 2014a, b). These studies
point to a tissue-specific signature of FOXO expression and
its partial role in regulating oxidative stress resistance and
autophagy. In vivo studies using FOXO cartilage-specific
KO mice or FOXO activators and inhibitors have not yet
been reported.
Another family of transcription factors, known as peroxi-
some proliferator-activated receptors (PPARs), have been
shown in recent studies to be involved in OA. PPARs are
ligand-activated transcription factors that are involved in
regulating glucose and lipid homeostasis, inflammation, pro-
liferation and differentiation (Peters et al. 2012). Three PPAR
isoforms, PPARa, PPARb/d (also known as PPARb or
PPARd) and PPARc, are found in all mammals (Peters et al.
2012). It has been known for some time that PPARc inhibits
IL-1b-induced proteoglycan degradation (Francois et al.
2006). Vasheghani et al. (2013) reported that (constitutive)
cartilage-specific disruption of PPARc results in spontaneous
OA in mice (14 months of age). The same group went on to
generate an inducible cartilage-specific PPARc KO mouse
(PPARc-cKO) (Vasheghani et al. 2015). Postnatal deletion of
PPARc in chondrocytes upon administration of doxycycline
did not lead to spontaneous OA, but the mice became more
susceptible to experimental OA (Vasheghani et al. 2015).
PPARc-cKO mice displayed increased expression of MMP13
and ADAMTS5, and had higher numbers of apoptotic chon-
drocytes in OA knee joints (Vasheghani et al. 2015). This
same group previously reported that mTOR KO mice were
protected from experimental OA by increasing autophagy
(Zhang et al. 2014). Therefore, the group tested the hypothesis
that accelerated OA in PPARc-cKO mice was due to
enhanced mTOR signalling. PPARc-cKO had increased
expression of mTOR and a decrease in autophagy markers in
naive and destabilised joints (Vasheghani et al. 2015). Dou-
ble-KO mice of mTOR and PPARc were protected from
surgically induced OA with a phenotype similar to that of the
previously published mTOR KO (Zhang et al. 2014; Vashe-
ghani et al. 2015). These studies support a role for PPARc in
mTOR-driven chondroprotection. Consistent with this,
Pioglitazone (a PPARc agonist) has been shown to reduce
cartilage lesions in an experimental dog model of OA (Boileau
et al. 2007). Studies to date make PPARc an attractive future
drug target for OA.
Studies have also been conducted to elucidate the role of
PPARa and PPARb/d in OA. Clockaerts et al. (2011)
reported that the PPARa agonist Wy-14643 inhibited mRNA
expression of MMP1, MMP3 and MMP13 in human OA
cartilage explants after IL-1b treatment but did not have an
effect on COL2A1 or aggrecan expression. This study sug-
gests a possible protective effect of PPARa in OA also. In
contrast, Ratneswaran et al. (2015) looked at the role of
PPARb/d in OA. PPARb/d activation by GW501516
increased expression of several proteases (MMP2, MMP3
and ADAMTS2) in murine chondrocytes and increased
aggrecan degradation and GAG release in knee joint
explants. Constitutive cartilage-specific PPARb/d KO dis-
played no developmental phenotype and showed marked
protection in the surgical destabilisation model of OA
(Ratneswaran et al. 2015). This study suggests PPARb/d to
have a possible protective role in OA. The role of each PPAR
isomer seems to be very distinct. Hence careful targeting of
these transcription factors might be required if one is to
envisage them being potential therapeutic targets in OA.
Conclusions and future directions
Recent advances in basic science have improved our
understanding of how cellular ageing may contribute to the
pathogenesis of OA. We now better appreciate the complex
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signalling networks that control metabolic processes and
regulators in articular chondrocytes. The dysregulation of
these factors may change cellular responses to inflamma-
tory and anabolic signals as well as affect the mechano-
responsiveness of the tissue (Fig. 3). How these pathways
are regulated in other joint tissues and the impact on the
intrinsic and extrinsic repair responses are unknown.
Pragmatic approaches to disease management will need to
include how changes in body weight, nutrition, exercise,
comorbidities and risk factors influence these cellular
responses to ageing in different OA patient cohorts
(Fig. 3). Specific pharmacological approaches targeted at
some of these pathways may be a realistic future vision.
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